Total Funding
29
63
Total FundingNon-equity Assistance raised
Growth Score
-2 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
68544
CytoVeris develops optical-based probes enabling surgical oncologists to identify and remove tumor tissue during cancer resection surgery.
- Alan Kersey: Founder, President & CEO
About the Company
CytoVeris develops optical-based technologies enabling surgical oncologists to identify and remove tumor tissue during cancer resection surgery.
The Company's devices help to improve the surgeon’s ability to ensure clean margins are attained. It also develops technology to detect molecular signatures that cancer cells create due to the way
that they hijack the cellular metabolic processes and corrupt DNA and protein pathways which creates signature variations of molecules such as lipids, proteins, and metabolites that can be detected with their OncoMap system.
It was formed by Alan Kersey in Farmington, Connecticut in 2018.
